AstraZeneca Pharma gets DCGI nod to market asthma drug

AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3nExsf1
via IFTTT